Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: Pharmacol Rev. 2007 Nov 30;60(1):1–42. doi: 10.1124/pr.107.07108

Figure 2.

Figure 2

Ability of the mammalian peptides, gastrin-releasing peptide (GRP) and neuromedin B NMB); the amphibian peptide, bombesin and the synthetic bombesin analogue, [D-Phe6, β-Ala11, Phe13, Nle14] bombesin 6−14 to interact with the three human classes of bombesin receptors. Data are partially from (Benya et al., 1995b; Ryan et al., 1998b).